0000791908-14-000002.txt : 20140110 0000791908-14-000002.hdr.sgml : 20140110 20140110150046 ACCESSION NUMBER: 0000791908-14-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140109 FILED AS OF DATE: 20140110 DATE AS OF CHANGE: 20140110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XOMA Corp CENTRAL INDEX KEY: 0000791908 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942756657 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2910 SEVENTH ST CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 5106441170 MAIL ADDRESS: STREET 1: 2910 SEVENTH ST CITY: BERKELEY STATE: CA ZIP: 94710 FORMER COMPANY: FORMER CONFORMED NAME: XOMA LTD /DE/ DATE OF NAME CHANGE: 19990107 FORMER COMPANY: FORMER CONFORMED NAME: XOMA CORP /DE/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCANNON PATRICK J MD PHD CENTRAL INDEX KEY: 0001222790 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14710 FILM NUMBER: 14521596 MAIL ADDRESS: STREET 1: C/O XOMA, LTD. STREET 2: 2910 SEVENTH STREET CITY: BERKELEY STATE: CA ZIP: 94710 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-01-09 0 0000791908 XOMA Corp XOMA 0001222790 SCANNON PATRICK J MD PHD C/O XOMA CORPORATION 2910 SEVENTH STREET BERKELEY CA 94710 1 1 0 0 Exec. VP & CSO Common Shares 2014-01-09 4 M 0 20000 1.69 A 62017 D Common Shares 2014-01-09 4 S 0 20000 8.0021 D 42017 D Common Shares 20339 I by 401(k) Common Shares 750 I by Daughter Common Shares 4053 I by Trust Non-Qualified Share Option (right to buy) 1.69 2014-01-09 4 M 0 20000 1.69 D 2013-10-28 2021-10-27 Common Shares 20000 18406 D This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on 3/20/2013. This transaction was executed in multiple trades ranging at prices from $8.00 to $8.02.The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected. By: Russell J. Wood For: Patrick J. Scannon, M.D., Ph.D. 2014-01-10